Endava stock falls as accounting investigation reshapes guidance

Published on 09/22/2026 at 07:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Endava stock traded at USD 2.80 on September 21, 2026, 69.66 percent below its one-year level. An interim CFO now leads amid an accounting review.

DAVA, US29260V1052, Illustration mit AI erstellt.

Endava plc (US29260V1052) traded at USD 2.80 on the NYSE on September 21, 2026, up USD 0.02, or 0.54 percent, from the previous close of USD 2.78. The company then disclosed an interim finance leadership change tied to an ongoing accounting investigation, making governance the immediate issue for Endava stock.

Interim CFO follows accounting review

According to Business Wire on September 21, 2026, Endava appointed Conor McShane of AlixPartners as interim chief financial officer after Mark Thurston was placed on administrative leave. The board initiated an investigation by independent outside counsel after concerns about the accounting treatment of certain customer and supplier agreements.

The disclosure adds a concrete counter-factor to the valuation picture. The same company announcement says Endava had 11,225 employees as of March 31, 2026, while the investigation may affect confidence in reported figures and the timing of future filings.

Results are scheduled by November 2

Business Wire reports that Endava intends to publish fiscal fourth-quarter and full-year 2026 results and file its Form 20-F by November 2, 2026. The company says it will announce the exact release and conference-call time once scheduled.

That date is the next firm reporting checkpoint in the announcement. It also creates a measurable comparison with the market data: Endava's USD 2.80 share price was 69.66 percent below its one-year level, while its 52-week range ran from USD 2.55 to USD 9.88 on the quoted snapshot.

Endava stock remains near yearly low

The market capitalization was USD 147.96 million and reported volume was 303,700 shares on the same market-data snapshot. The price stood USD 0.25 above the 52-week low and USD 7.08 below the high, leaving the stock much closer to the bottom of its range than to the top.

For investors, the November filing deadline and the accounting review matter more immediately than a model-based valuation figure. The investigation, the interim CFO appointment and the next full-year filing now form the clearest dated framework for assessing whether reported operating performance can regain credibility.

Stock trades at USD 2.80

Endava stock was quoted at USD 2.80 on the NYSE as of September 21, 2026, with a daily gain of 0.54 percent and a previous close of USD 2.78. The market capitalization was USD 147.96 million on that snapshot.